BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Accenture
Deloitte
US Army
Fish and Richardson
Cipla
Teva
Boehringer Ingelheim
Baxter
Merck

Generated: January 22, 2018

DrugPatentWatch Database Preview

ISOPROTERENOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Isoproterenol Hydrochloride, and when can generic versions of Isoproterenol Hydrochloride launch?

Isoproterenol Hydrochloride is a drug marketed by 3M, Alpharma Us Pharms, Abraxis Pharm, Baxter Hlthcare, Hospira, Intl Medication, Nexus Pharms, Armour Pharm, DEY, and Parke Davis. and is included in thirteen NDAs.

The generic ingredient in ISOPROTERENOL HYDROCHLORIDE is isoproterenol hydrochloride. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.

US Patents and Regulatory Information for ISOPROTERENOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride AEROSOL, METERED;INHALATION 010375-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083724-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083486-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 085994-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nexus Pharms ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 206961-001 Aug 2, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride AEROSOL, METERED;INHALATION 085904-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083431-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083346-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083283-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Armour Pharm ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 087936-001 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
US Army
Johnson and Johnson
Accenture
Chubb
Cantor Fitzgerald
Fuji
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot